427 related articles for article (PubMed ID: 32737518)
1. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
2. Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
Luining WI; Oprea-Lager DE; Vis AN; van Moorselaar RJA; Knol RJJ; Wondergem M; Boellaard R; Cysouw MCF
PLoS One; 2023; 18(11):e0293672. PubMed ID: 37943772
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with
Yao F; Bian S; Zhu D; Yuan Y; Pan K; Pan Z; Feng X; Tang K; Yang Y
Radiol Med; 2022 Oct; 127(10):1170-1178. PubMed ID: 36018488
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on
Yi Z; Hu S; Lin X; Zou Q; Zou M; Zhang Z; Xu L; Jiang N; Zhang Y
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1523-1534. PubMed ID: 34845536
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lymph-node staging with
Jansen BHE; Bodar YJL; Zwezerijnen GJC; Meijer D; van der Voorn JP; Nieuwenhuijzen JA; Wondergem M; Roeleveld TA; Boellaard R; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):509-520. PubMed ID: 32789599
[TBL] [Abstract][Full Text] [Related]
6. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
Papp L; Spielvogel CP; Grubmüller B; Grahovac M; Krajnc D; Ecsedi B; Sareshgi RAM; Mohamad D; Hamboeck M; Rausch I; Mitterhauser M; Wadsak W; Haug AR; Kenner L; Mazal P; Susani M; Hartenbach S; Baltzer P; Helbich TH; Kramer G; Shariat SF; Beyer T; Hartenbach M; Hacker M
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1795-1805. PubMed ID: 33341915
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate cancer with
Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250
[TBL] [Abstract][Full Text] [Related]
9. Repeatability of Quantitative
Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
[TBL] [Abstract][Full Text] [Related]
10. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract][Full Text] [Related]
11. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.
Meijer D; van Leeuwen PJ; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Oprea-Lager DE; Coughlin GD; Vis AN
Eur Urol; 2021 Aug; 80(2):234-242. PubMed ID: 34024652
[TBL] [Abstract][Full Text] [Related]
12. Performance of
Li Y; Li F; Han S; Ning J; Su P; Liu J; Qu L; Huang S; Wang S; Li X; Li X
Phenomics; 2023 Dec; 3(6):576-585. PubMed ID: 38223686
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer.
Zheng H; Miao Q; Liu Y; Mirak SA; Hosseiny M; Scalzo F; Raman SS; Sung K
Eur Radiol; 2022 Aug; 32(8):5688-5699. PubMed ID: 35238971
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
15. Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.
Hinsenveld FJ; Wit EMK; van Leeuwen PJ; Brouwer OR; Donswijk ML; Tillier CN; Vegt E; van Muilekom E; van Oosterom MN; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2020 Apr; 61(4):540-545. PubMed ID: 31562222
[TBL] [Abstract][Full Text] [Related]
16. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of
Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
[TBL] [Abstract][Full Text] [Related]
19. The role of [
Basso Dias A; Mirshahvalad SA; Ortega C; Perlis N; Berlin A; van der Kwast T; Ghai S; Jhaveri K; Metser U; Haider M; Avery L; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2167-2176. PubMed ID: 36809425
[TBL] [Abstract][Full Text] [Related]
20. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference.
Zamboglou C; Carles M; Fechter T; Kiefer S; Reichel K; Fassbender TF; Bronsert P; Koeber G; Schilling O; Ruf J; Werner M; Jilg CA; Baltas D; Mix M; Grosu AL
Theranostics; 2019; 9(9):2595-2605. PubMed ID: 31131055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
